miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase
Crossref DOI link: https://doi.org/10.1186/s12967-015-0435-y
Published Online: 2015-02-21
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Huiyuan
Li, Xinyi
Li, Wenbin
Zheng, Huyong
License valid from 2015-02-21
Article History
Received: 16 November 2014
Accepted: 11 February 2015
First Online: 21 February 2015